JD Supra Law

OCTOBER 26, 2022

Patent and Trademark Office (USPTO) recently published a request for comments addressing a variety of topics related to generic drug and biosimilar competition.

Publishing 97

Publishing Trademark Patent 97

LexBlog IP

OCTOBER 25, 2022

Patent and Trademark Office (USPTO) recently published a request for comments addressing a variety of topics related to generic drug and biosimilar competition. ” The USPTO now seeks public comment on the following questions with regards to the initiatives proposed by the USPTO.

Invention 52

Invention Patent Prosecution Art Patent 52

Fish & Richardson Trademark & Copyright Thoughts

JANUARY 11, 2022

Introduction. 2021 saw several important milestones in the biosimilars space, including the much anticipated first interchangeable designations by FDA and the approval of the first ophthalmology biosimilar. The biosimilar market also exhibited continued growth, with multiple biosimilar developers reporting strong sales of biosimilars through 2021.

Litigation 52

Litigation Settlement Patent Marketing 52

Technology & Marketing Law Blog

SEPTEMBER 15, 2023

Clearly, this topic is rapidly evolving, and it will almost certainly end up on the Supreme Court’s main docket (not just the shadow docket) soon.] * * * Twitter suspended users or deboosted their tweets based on its COVID misinformation policy. My prior blog post on the district court ruling.

Government 102

Government Blogging Social Media Litigation 102